{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:52:42Z","timestamp":1790776362826,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T00:00:00Z","timestamp":1281830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00270-010-9964-1","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T08:25:19Z","timestamp":1281774319000},"page":"132-138","source":"Crossref","is-referenced-by-count":179,"title":["Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study"],"prefix":"10.1007","volume":"34","author":[{"given":"Maciej","family":"Pech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Janitzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann Jacob","family":"Wendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Strang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Dudeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe-Bernd","family":"Liehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,15]]},"reference":[{"key":"9964_CR1","doi-asserted-by":"crossref","unstructured":"Bertacchini C, Margotti PM, Bergamini E, Lodi A, Ronchetti M, Cadossi R (2007) Design of an irreversible electroporation system for clinical use. Technol Cancer Res Treat 6(4):313\u2013320","DOI":"10.1177\/153303460700600408"},{"key":"9964_CR2","doi-asserted-by":"crossref","unstructured":"Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality\u2014clinical implications. Technol Cancer Res Treat 6(1):37\u201348","DOI":"10.1177\/153303460700600106"},{"key":"9964_CR3","doi-asserted-by":"crossref","unstructured":"Rubinsky B (2007) Irreversible electroporation in medicine. Technol Cancer Res Treat 6(4):255\u2013260","DOI":"10.1177\/153303460700600401"},{"key":"9964_CR4","doi-asserted-by":"crossref","unstructured":"Hines-Peralta A, Goldberg SN (2004) Review of radiofrequency ablation for renal cell carcinoma. Clin Cancer Res 10(18 Pt 2):6328S\u20136334S","DOI":"10.1158\/1078-0432.CCR-050004"},{"key":"9964_CR5","doi-asserted-by":"crossref","unstructured":"Yoon SK, Choi JC, Cho JH, Oh JY, Nam KJ et al (2009) Radiofrequency ablation of renal VX2 tumors with and without renal artery occlusion in a rabbit model: feasibility, therapeutic efficacy, and safety. Cardiovasc Intervent Radiol 32(6):1241\u20131246","DOI":"10.1007\/s00270-009-9621-8"},{"key":"9964_CR6","doi-asserted-by":"crossref","unstructured":"Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard JJ et al (2007) Renal cell carcinoma guideline. Eur Urol 51(6):1502\u20131510","DOI":"10.1016\/j.eururo.2007.03.035"},{"key":"9964_CR7","doi-asserted-by":"crossref","unstructured":"Al Sakere B, Andr\u00e9 F, Bernat C, Connault E, Opolon P, Davalos RV, et al (2007) Tumor ablation with irreversible electroporation. PLoS One 2(11):e1135","DOI":"10.1371\/journal.pone.0001135"},{"key":"9964_CR8","doi-asserted-by":"crossref","unstructured":"Garcia PA, Rossmeisl JH, Robertson J, Ellis TL, Davalos RV (2009) Pilot study of irreversible electroporation for intracranial surgery. Conf Proc IEEE Eng Med Biol Soc 1:6513\u20136516","DOI":"10.1109\/IEMBS.2009.5333141"},{"issue":"16","key":"9964_CR9","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1088\/0031-9155\/54\/16\/006","volume":"54","author":"Y Granot","year":"2009","unstructured":"Granot Y, Ivorra A, Maor E, Rubinsky B (2009) In vivo imaging of irreversible electroporation by means of electrical impedance tomography. Phys Med Biol 54(16):4927\u20134943","journal-title":"Phys Med Biol"},{"issue":"4","key":"9964_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/153303460700600405","volume":"6","author":"G Onik","year":"2007","unstructured":"Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6(4):295\u2013300","journal-title":"Technol Cancer Res Treat"},{"key":"9964_CR11","doi-asserted-by":"crossref","unstructured":"Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H (2005) Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 173(6):1889\u20131892","DOI":"10.1097\/01.ju.0000158043.94525.d6"},{"issue":"6","key":"9964_CR12","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0022-5347(05)68071-8","volume":"162","author":"KS Hafez","year":"1999","unstructured":"Hafez KS, Fergany AF, Novick AC (1999) Nephron-sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 162(6):1930\u20131933","journal-title":"J Urol"},{"key":"9964_CR13","first-page":"428","volume-title":"Renal diseases","author":"ET Bell","year":"1950","unstructured":"Bell ET (1950) Renal diseases. Lippincott, Philadelphia, PA, pp 428\u2013439"},{"key":"9964_CR14","first-page":"85","volume-title":"Urologic pathology","author":"RO Peterson","year":"1986","unstructured":"Peterson RO (1986) Urologic pathology. Lippincott, Philadelphia, PA, pp 85\u2013110"},{"issue":"4","key":"9964_CR15","first-page":"267","volume":"13","author":"MA Bosniak","year":"1995","unstructured":"Bosniak MA (1995) Observation of small incidentally detected renal masses. Semin Urol Oncol 13(4):267\u2013272","journal-title":"Semin Urol Oncol"},{"key":"9964_CR16","unstructured":"Nissenkorn, Bernhelm J (1995) Multicentricity in renal cell carcinoma. J Urol 153(3 Pt 1):620\u2013622"},{"key":"9964_CR17","doi-asserted-by":"crossref","unstructured":"Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175(2):425\u2013431","DOI":"10.1016\/S0022-5347(05)00148-5"},{"key":"9964_CR18","doi-asserted-by":"crossref","unstructured":"Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ (2003) Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 180(6):1503\u20131508","DOI":"10.2214\/ajr.180.6.1801503"},{"key":"9964_CR19","doi-asserted-by":"crossref","unstructured":"Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC (2002) Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J Urol 168(6):2401\u20132405","DOI":"10.1016\/S0022-5347(05)64154-7"},{"issue":"2","key":"9964_CR20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1148\/radiol.2262012062","volume":"226","author":"DA Gervais","year":"2003","unstructured":"Gervais DA, McGovern FJ, Arellano RS (2003) Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 226(2):417\u2013424","journal-title":"Radiology"},{"key":"9964_CR21","unstructured":"Pavlovich C, Walther M, Choyke P, Pautler SE, Chang R, Linehan WM et al (2002) Percutaneous radiofrequency ablation of small renal tumors: initial results. J Urol 167(1):10\u201315"},{"key":"9964_CR22","doi-asserted-by":"crossref","unstructured":"Tacke J, Mahnken A, Bucker A, Rohde D, G\u00fcnther RW (2001) Nephron-sparing percutaneous ablation of a 5\u00a0cm renal cell carcinoma by superselective embolization and percutaneous RF-ablation. Rofo 173(11):980\u2013983","DOI":"10.1055\/s-2001-18309"},{"key":"9964_CR23","doi-asserted-by":"crossref","unstructured":"Gebauer B, Werk M, Lopez-Hanninen E, Felix R, Althaus P (2007) Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy. Cardiovasc Intervent Radiol 30(4):644\u2013649","DOI":"10.1007\/s00270-007-9012-y"},{"issue":"2","key":"9964_CR24","first-page":"143","volume":"3","author":"RE Dib","year":"2009","unstructured":"Dib RE, Touma NJ, Kapoor A (2009) Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. Can Urol Assoc J 3(2):143\u2013149","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"9964_CR25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/153303460700600404","volume":"6","author":"EW Lee","year":"2007","unstructured":"Lee EW, Loh CT, Kee ST (2007) Imaging-guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6(4):287\u2013294","journal-title":"Technol Cancer Res Treat"},{"key":"9964_CR26","doi-asserted-by":"crossref","unstructured":"Maor E, Ivorra A, Leor J, Rubinsky B (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6(4):307\u2013312","DOI":"10.1177\/153303460700600407"},{"issue":"6","key":"9964_CR27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/153303460500400615","volume":"4","author":"L Miller","year":"2005","unstructured":"Miller L, Leor J, Rubinsky B (2005) Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4(6):699\u2013705","journal-title":"Technol Cancer Res Treat"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-010-9964-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-010-9964-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-010-9964-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:57:15Z","timestamp":1559426235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-010-9964-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["9964"],"URL":"https:\/\/doi.org\/10.1007\/s00270-010-9964-1","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,15]]}}}